nodes	percent_of_prediction	percent_of_DWPC	metapath
Glyburide—SLCO1A2—epilepsy syndrome	0.106	0.288	CbGaD
Glyburide—KCNJ11—epilepsy syndrome	0.0934	0.254	CbGaD
Glyburide—ABCC2—epilepsy syndrome	0.0505	0.138	CbGaD
Glyburide—ABCG2—epilepsy syndrome	0.0446	0.122	CbGaD
Glyburide—CYP2C19—epilepsy syndrome	0.0351	0.0956	CbGaD
Glyburide—ABCC3—Phenobarbital—epilepsy syndrome	0.0216	0.0574	CbGbCtD
Glyburide—ABCC2—Levetiracetam—epilepsy syndrome	0.0214	0.0568	CbGbCtD
Glyburide—ALB—epilepsy syndrome	0.0195	0.053	CbGaD
Glyburide—ABCB11—Phenobarbital—epilepsy syndrome	0.0187	0.0496	CbGbCtD
Glyburide—ABCB1—epilepsy syndrome	0.0186	0.0506	CbGaD
Glyburide—ABCC1—Phenobarbital—epilepsy syndrome	0.0133	0.0353	CbGbCtD
Glyburide—SLC22A7—Valproic Acid—epilepsy syndrome	0.0126	0.0336	CbGbCtD
Glyburide—ABCC2—Carbamazepine—epilepsy syndrome	0.0123	0.0327	CbGbCtD
Glyburide—ALB—Oxcarbazepine—epilepsy syndrome	0.0122	0.0324	CbGbCtD
Glyburide—ABCC2—Phenytoin—epilepsy syndrome	0.011	0.0293	CbGbCtD
Glyburide—ALB—Fosphenytoin—epilepsy syndrome	0.0107	0.0283	CbGbCtD
Glyburide—ABCC2—Phenobarbital—epilepsy syndrome	0.00984	0.0261	CbGbCtD
Glyburide—ALB—Clonazepam—epilepsy syndrome	0.00965	0.0256	CbGbCtD
Glyburide—CYP2C19—Oxcarbazepine—epilepsy syndrome	0.00792	0.021	CbGbCtD
Glyburide—ALB—Rufinamide—epilepsy syndrome	0.00787	0.0209	CbGbCtD
Glyburide—CYP2C19—Trimethadione—epilepsy syndrome	0.00736	0.0195	CbGbCtD
Glyburide—CYP2C19—Felbamate—epilepsy syndrome	0.00736	0.0195	CbGbCtD
Glyburide—SLC22A6—Acetazolamide—epilepsy syndrome	0.0072	0.0191	CbGbCtD
Glyburide—ABCB1—Levetiracetam—epilepsy syndrome	0.00698	0.0185	CbGbCtD
Glyburide—CYP2C19—Fosphenytoin—epilepsy syndrome	0.00692	0.0184	CbGbCtD
Glyburide—ALB—Phenytoin—epilepsy syndrome	0.00688	0.0183	CbGbCtD
Glyburide—ALB—Propofol—epilepsy syndrome	0.00641	0.017	CbGbCtD
Glyburide—CYP2C9—Trimethadione—epilepsy syndrome	0.00612	0.0162	CbGbCtD
Glyburide—CYP2C19—Clobazam—epilepsy syndrome	0.006	0.0159	CbGbCtD
Glyburide—ALB—Diazepam—epilepsy syndrome	0.00581	0.0154	CbGbCtD
Glyburide—CYP2C9—Fosphenytoin—epilepsy syndrome	0.00575	0.0153	CbGbCtD
Glyburide—SLC22A6—Valproic Acid—epilepsy syndrome	0.00538	0.0143	CbGbCtD
Glyburide—CYP2C19—Carbamazepine—epilepsy syndrome	0.00497	0.0132	CbGbCtD
Glyburide—ABCB1—Clobazam—epilepsy syndrome	0.00484	0.0128	CbGbCtD
Glyburide—ABCB1—Lamotrigine—epilepsy syndrome	0.00466	0.0124	CbGbCtD
Glyburide—CYP2C19—Primidone—epilepsy syndrome	0.00464	0.0123	CbGbCtD
Glyburide—CYP2C19—Phenytoin—epilepsy syndrome	0.00446	0.0118	CbGbCtD
Glyburide—CYP2C19—Propofol—epilepsy syndrome	0.00416	0.011	CbGbCtD
Glyburide—CYP2C9—Carbamazepine—epilepsy syndrome	0.00413	0.011	CbGbCtD
Glyburide—ABCB1—Carbamazepine—epilepsy syndrome	0.00401	0.0106	CbGbCtD
Glyburide—CYP2C19—Phenobarbital—epilepsy syndrome	0.00397	0.0105	CbGbCtD
Glyburide—CYP2C9—Primidone—epilepsy syndrome	0.00386	0.0102	CbGbCtD
Glyburide—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.00383	0.0102	CbGbCtD
Glyburide—CYP2C19—Diazepam—epilepsy syndrome	0.00377	0.01	CbGbCtD
Glyburide—CYP2C9—Phenytoin—epilepsy syndrome	0.00371	0.00984	CbGbCtD
Glyburide—CYP2C19—Zonisamide—epilepsy syndrome	0.00368	0.00976	CbGbCtD
Glyburide—ABCB1—Phenytoin—epilepsy syndrome	0.0036	0.00955	CbGbCtD
Glyburide—CYP3A4—Trimethadione—epilepsy syndrome	0.00356	0.00944	CbGbCtD
Glyburide—CYP3A4—Felbamate—epilepsy syndrome	0.00356	0.00944	CbGbCtD
Glyburide—CYP2C9—Propofol—epilepsy syndrome	0.00346	0.00917	CbGbCtD
Glyburide—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00334	0.00888	CbGbCtD
Glyburide—CYP2C9—Phenobarbital—epilepsy syndrome	0.0033	0.00877	CbGbCtD
Glyburide—ABCB1—Phenobarbital—epilepsy syndrome	0.00321	0.00851	CbGbCtD
Glyburide—ABCB1—Midazolam—epilepsy syndrome	0.00316	0.00839	CbGbCtD
Glyburide—CYP2C9—Diazepam—epilepsy syndrome	0.00313	0.00831	CbGbCtD
Glyburide—ABCB1—Diazepam—epilepsy syndrome	0.00304	0.00807	CbGbCtD
Glyburide—CYP3A4—Clonazepam—epilepsy syndrome	0.00302	0.00803	CbGbCtD
Glyburide—CYP2C19—Valproic Acid—epilepsy syndrome	0.00297	0.00788	CbGbCtD
Glyburide—CYP3A4—Clobazam—epilepsy syndrome	0.0029	0.0077	CbGbCtD
Glyburide—CYP2C19—Topiramate—epilepsy syndrome	0.00268	0.00711	CbGbCtD
Glyburide—KCNJ5—hindbrain—epilepsy syndrome	0.00255	0.0815	CbGeAlD
Glyburide—CYP2C9—Valproic Acid—epilepsy syndrome	0.00247	0.00655	CbGbCtD
Glyburide—CYP3A4—Rufinamide—epilepsy syndrome	0.00247	0.00654	CbGbCtD
Glyburide—CYP3A4—Carbamazepine—epilepsy syndrome	0.0024	0.00638	CbGbCtD
Glyburide—CYP3A4—Primidone—epilepsy syndrome	0.00224	0.00595	CbGbCtD
Glyburide—CYP3A4—Phenytoin—epilepsy syndrome	0.00216	0.00572	CbGbCtD
Glyburide—CYP3A4—Propofol—epilepsy syndrome	0.00201	0.00533	CbGbCtD
Glyburide—CYP3A4—Phenobarbital—epilepsy syndrome	0.00192	0.0051	CbGbCtD
Glyburide—CYP3A4—Acetazolamide—epilepsy syndrome	0.00192	0.0051	CbGbCtD
Glyburide—CYP3A4—Midazolam—epilepsy syndrome	0.00189	0.00503	CbGbCtD
Glyburide—CYP3A4—Diazepam—epilepsy syndrome	0.00182	0.00483	CbGbCtD
Glyburide—CYP3A4—Zonisamide—epilepsy syndrome	0.00178	0.00472	CbGbCtD
Glyburide—KCNJ5—brainstem—epilepsy syndrome	0.00146	0.0467	CbGeAlD
Glyburide—CYP3A4—Valproic Acid—epilepsy syndrome	0.00144	0.00381	CbGbCtD
Glyburide—CYP3A4—Topiramate—epilepsy syndrome	0.0013	0.00344	CbGbCtD
Glyburide—KCNJ5—head—epilepsy syndrome	0.000809	0.0258	CbGeAlD
Glyburide—SLCO2B1—ganglion—epilepsy syndrome	0.000795	0.0254	CbGeAlD
Glyburide—KCNJ5—nervous system—epilepsy syndrome	0.000767	0.0245	CbGeAlD
Glyburide—KCNJ1—forebrain—epilepsy syndrome	0.000763	0.0244	CbGeAlD
Glyburide—KCNJ5—central nervous system—epilepsy syndrome	0.000738	0.0236	CbGeAlD
Glyburide—ABCA1—forebrain—epilepsy syndrome	0.000725	0.0232	CbGeAlD
Glyburide—KCNJ5—cerebellum—epilepsy syndrome	0.000721	0.023	CbGeAlD
Glyburide—CPT1A—telencephalon—epilepsy syndrome	0.000716	0.0229	CbGeAlD
Glyburide—KCNJ1—telencephalon—epilepsy syndrome	0.000701	0.0224	CbGeAlD
Glyburide—ABCA1—telencephalon—epilepsy syndrome	0.000667	0.0213	CbGeAlD
Glyburide—KCNJ5—brain—epilepsy syndrome	0.000586	0.0187	CbGeAlD
Glyburide—Gliquidone—KCNJ11—epilepsy syndrome	0.000468	0.142	CrCbGaD
Glyburide—ABCA1—spinal cord—epilepsy syndrome	0.000467	0.0149	CbGeAlD
Glyburide—CPT1A—head—epilepsy syndrome	0.000446	0.0142	CbGeAlD
Glyburide—ABCC9—brain—epilepsy syndrome	0.000444	0.0142	CbGeAlD
Glyburide—ABCC8—brainstem—epilepsy syndrome	0.000441	0.0141	CbGeAlD
Glyburide—KCNJ1—head—epilepsy syndrome	0.000437	0.0139	CbGeAlD
Glyburide—ABCC8—forebrain—epilepsy syndrome	0.000426	0.0136	CbGeAlD
Glyburide—ABCA1—head—epilepsy syndrome	0.000415	0.0133	CbGeAlD
Glyburide—KCNJ1—nervous system—epilepsy syndrome	0.000414	0.0132	CbGeAlD
Glyburide—KCNJ1—central nervous system—epilepsy syndrome	0.000399	0.0127	CbGeAlD
Glyburide—CPT1A—cerebellum—epilepsy syndrome	0.000398	0.0127	CbGeAlD
Glyburide—ABCA1—nervous system—epilepsy syndrome	0.000394	0.0126	CbGeAlD
Glyburide—CFTR—head—epilepsy syndrome	0.000392	0.0125	CbGeAlD
Glyburide—ABCC8—telencephalon—epilepsy syndrome	0.000392	0.0125	CbGeAlD
Glyburide—ABCA1—central nervous system—epilepsy syndrome	0.000379	0.0121	CbGeAlD
Glyburide—Tolazamide—KCNJ11—epilepsy syndrome	0.000374	0.114	CrCbGaD
Glyburide—ABCA1—cerebellum—epilepsy syndrome	0.000371	0.0118	CbGeAlD
Glyburide—Glisoxepide—KCNJ11—epilepsy syndrome	0.000338	0.103	CrCbGaD
Glyburide—SLCO2B1—forebrain—epilepsy syndrome	0.000333	0.0107	CbGeAlD
Glyburide—Glimepiride—KCNJ11—epilepsy syndrome	0.000333	0.101	CrCbGaD
Glyburide—CPT1A—brain—epilepsy syndrome	0.000323	0.0103	CbGeAlD
Glyburide—KCNJ1—brain—epilepsy syndrome	0.000316	0.0101	CbGeAlD
Glyburide—ABCC8—medulla oblongata—epilepsy syndrome	0.000308	0.00983	CbGeAlD
Glyburide—SLCO1A2—forebrain—epilepsy syndrome	0.000307	0.0098	CbGeAlD
Glyburide—SLCO2B1—telencephalon—epilepsy syndrome	0.000307	0.00979	CbGeAlD
Glyburide—ABCA1—brain—epilepsy syndrome	0.000301	0.00962	CbGeAlD
Glyburide—Glipizide—KCNJ11—epilepsy syndrome	0.000289	0.0879	CrCbGaD
Glyburide—CFTR—brain—epilepsy syndrome	0.000284	0.00908	CbGeAlD
Glyburide—SLCO1A2—telencephalon—epilepsy syndrome	0.000282	0.00901	CbGeAlD
Glyburide—ABCC8—midbrain—epilepsy syndrome	0.000281	0.00899	CbGeAlD
Glyburide—ABCC8—spinal cord—epilepsy syndrome	0.000274	0.00877	CbGeAlD
Glyburide—Gliclazide—KCNJ11—epilepsy syndrome	0.000269	0.0817	CrCbGaD
Glyburide—KCNJ11—head—epilepsy syndrome	0.000265	0.00846	CbGeAlD
Glyburide—KCNJ11—nervous system—epilepsy syndrome	0.000251	0.00802	CbGeAlD
Glyburide—ABCC8—head—epilepsy syndrome	0.000244	0.00779	CbGeAlD
Glyburide—KCNJ11—central nervous system—epilepsy syndrome	0.000242	0.00772	CbGeAlD
Glyburide—SLCO2B1—medulla oblongata—epilepsy syndrome	0.000241	0.0077	CbGeAlD
Glyburide—KCNJ11—cerebellum—epilepsy syndrome	0.000236	0.00755	CbGeAlD
Glyburide—SLC15A2—telencephalon—epilepsy syndrome	0.000234	0.00748	CbGeAlD
Glyburide—ABCC1—telencephalon—epilepsy syndrome	0.000232	0.0074	CbGeAlD
Glyburide—ABCC8—nervous system—epilepsy syndrome	0.000231	0.00739	CbGeAlD
Glyburide—ABCC8—central nervous system—epilepsy syndrome	0.000223	0.00711	CbGeAlD
Glyburide—SLCO1A2—medulla oblongata—epilepsy syndrome	0.000222	0.00708	CbGeAlD
Glyburide—ABCC8—cerebellum—epilepsy syndrome	0.000218	0.00695	CbGeAlD
Glyburide—SLCO2B1—spinal cord—epilepsy syndrome	0.000215	0.00686	CbGeAlD
Glyburide—SLC22A7—brain—epilepsy syndrome	0.00021	0.00672	CbGeAlD
Glyburide—Chlorpropamide—KCNJ11—epilepsy syndrome	0.000209	0.0635	CrCbGaD
Glyburide—Gliclazide—VEGFA—epilepsy syndrome	0.000208	0.0633	CrCbGaD
Glyburide—ABCC3—head—epilepsy syndrome	0.000205	0.00654	CbGeAlD
Glyburide—SLC22A6—brain—epilepsy syndrome	0.000203	0.00649	CbGeAlD
Glyburide—SLCO1A2—midbrain—epilepsy syndrome	0.000203	0.00647	CbGeAlD
Glyburide—SLCO1A2—spinal cord—epilepsy syndrome	0.000198	0.00631	CbGeAlD
Glyburide—ABCC3—nervous system—epilepsy syndrome	0.000194	0.0062	CbGeAlD
Glyburide—KCNJ11—brain—epilepsy syndrome	0.000192	0.00613	CbGeAlD
Glyburide—ABCG2—telencephalon—epilepsy syndrome	0.000192	0.00612	CbGeAlD
Glyburide—SLCO2B1—head—epilepsy syndrome	0.000191	0.0061	CbGeAlD
Glyburide—ABCC3—central nervous system—epilepsy syndrome	0.000187	0.00597	CbGeAlD
Glyburide—SLC15A2—medulla oblongata—epilepsy syndrome	0.000184	0.00588	CbGeAlD
Glyburide—SLCO2B1—nervous system—epilepsy syndrome	0.000181	0.00578	CbGeAlD
Glyburide—ABCC8—brain—epilepsy syndrome	0.000177	0.00565	CbGeAlD
Glyburide—SLCO1A2—head—epilepsy syndrome	0.000176	0.00561	CbGeAlD
Glyburide—SLCO2B1—central nervous system—epilepsy syndrome	0.000174	0.00557	CbGeAlD
Glyburide—SLCO2B1—cerebellum—epilepsy syndrome	0.00017	0.00544	CbGeAlD
Glyburide—Sulpiride—BCHE—epilepsy syndrome	0.000169	0.0515	CrCbGaD
Glyburide—SLC15A2—midbrain—epilepsy syndrome	0.000168	0.00537	CbGeAlD
Glyburide—SLCO1A2—nervous system—epilepsy syndrome	0.000167	0.00532	CbGeAlD
Glyburide—SLC15A2—spinal cord—epilepsy syndrome	0.000164	0.00524	CbGeAlD
Glyburide—SLCO1A2—central nervous system—epilepsy syndrome	0.00016	0.00512	CbGeAlD
Glyburide—SLCO1A2—cerebellum—epilepsy syndrome	0.000157	0.00501	CbGeAlD
Glyburide—ABCG2—medulla oblongata—epilepsy syndrome	0.000151	0.00481	CbGeAlD
Glyburide—Zafirlukast—ABCG2—epilepsy syndrome	0.000149	0.0454	CrCbGaD
Glyburide—ABCC3—brain—epilepsy syndrome	0.000148	0.00474	CbGeAlD
Glyburide—SLC15A2—head—epilepsy syndrome	0.000146	0.00466	CbGeAlD
Glyburide—SLCO2B1—brain—epilepsy syndrome	0.000138	0.00442	CbGeAlD
Glyburide—SLC15A2—nervous system—epilepsy syndrome	0.000138	0.00442	CbGeAlD
Glyburide—ABCG2—midbrain—epilepsy syndrome	0.000138	0.0044	CbGeAlD
Glyburide—ABCG2—spinal cord—epilepsy syndrome	0.000134	0.00429	CbGeAlD
Glyburide—SLC15A2—central nervous system—epilepsy syndrome	0.000133	0.00425	CbGeAlD
Glyburide—SLC15A2—cerebellum—epilepsy syndrome	0.00013	0.00415	CbGeAlD
Glyburide—ABCC1—cerebellum—epilepsy syndrome	0.000129	0.00411	CbGeAlD
Glyburide—SLCO1A2—brain—epilepsy syndrome	0.000127	0.00407	CbGeAlD
Glyburide—ALB—brain—epilepsy syndrome	0.000127	0.00404	CbGeAlD
Glyburide—Zafirlukast—CYP2C19—epilepsy syndrome	0.000117	0.0357	CrCbGaD
Glyburide—ABCG2—cerebellum—epilepsy syndrome	0.000106	0.0034	CbGeAlD
Glyburide—SLC15A2—brain—epilepsy syndrome	0.000106	0.00337	CbGeAlD
Glyburide—ABCC1—brain—epilepsy syndrome	0.000104	0.00334	CbGeAlD
Glyburide—ABCB1—forebrain—epilepsy syndrome	0.000103	0.00328	CbGeAlD
Glyburide—Gliclazide—CYP2C19—epilepsy syndrome	0.000101	0.0307	CrCbGaD
Glyburide—ABCB1—telencephalon—epilepsy syndrome	9.45e-05	0.00302	CbGeAlD
Glyburide—Zafirlukast—CYP2D6—epilepsy syndrome	8.7e-05	0.0264	CrCbGaD
Glyburide—ABCG2—brain—epilepsy syndrome	8.65e-05	0.00276	CbGeAlD
Glyburide—CYP3A4—nervous system—epilepsy syndrome	7.88e-05	0.00252	CbGeAlD
Glyburide—Chlorpropamide—CYP2C19—epilepsy syndrome	7.85e-05	0.0239	CrCbGaD
Glyburide—CYP3A4—central nervous system—epilepsy syndrome	7.59e-05	0.00242	CbGeAlD
Glyburide—ABCB1—medulla oblongata—epilepsy syndrome	7.43e-05	0.00237	CbGeAlD
Glyburide—ABCB1—midbrain—epilepsy syndrome	6.79e-05	0.00217	CbGeAlD
Glyburide—ABCB1—spinal cord—epilepsy syndrome	6.62e-05	0.00212	CbGeAlD
Glyburide—Pruritus—Vigabatrin—epilepsy syndrome	6.08e-05	0.000518	CcSEcCtD
Glyburide—Asthenia—Diazepam—epilepsy syndrome	6.07e-05	0.000517	CcSEcCtD
Glyburide—Urticaria—Oxcarbazepine—epilepsy syndrome	6.06e-05	0.000516	CcSEcCtD
Glyburide—Nausea—Acetazolamide—epilepsy syndrome	6.05e-05	0.000515	CcSEcCtD
Glyburide—Feeling abnormal—Carbamazepine—epilepsy syndrome	6.04e-05	0.000514	CcSEcCtD
Glyburide—Abdominal pain—Oxcarbazepine—epilepsy syndrome	6.03e-05	0.000514	CcSEcCtD
Glyburide—Diarrhoea—Fosphenytoin—epilepsy syndrome	6.03e-05	0.000514	CcSEcCtD
Glyburide—Vomiting—Propofol—epilepsy syndrome	6.01e-05	0.000512	CcSEcCtD
Glyburide—Gastrointestinal pain—Carbamazepine—epilepsy syndrome	5.99e-05	0.00051	CcSEcCtD
Glyburide—Pruritus—Diazepam—epilepsy syndrome	5.99e-05	0.00051	CcSEcCtD
Glyburide—Rash—Propofol—epilepsy syndrome	5.96e-05	0.000508	CcSEcCtD
Glyburide—Dermatitis—Propofol—epilepsy syndrome	5.96e-05	0.000507	CcSEcCtD
Glyburide—Headache—Propofol—epilepsy syndrome	5.92e-05	0.000504	CcSEcCtD
Glyburide—Hypersensitivity—Zonisamide—epilepsy syndrome	5.91e-05	0.000503	CcSEcCtD
Glyburide—ABCB1—head—epilepsy syndrome	5.89e-05	0.00188	CbGeAlD
Glyburide—Vomiting—Midazolam—epilepsy syndrome	5.88e-05	0.000501	CcSEcCtD
Glyburide—Diarrhoea—Vigabatrin—epilepsy syndrome	5.88e-05	0.000501	CcSEcCtD
Glyburide—Asthenia—Felbamate—epilepsy syndrome	5.87e-05	0.0005	CcSEcCtD
Glyburide—Vision blurred—Pregabalin—epilepsy syndrome	5.87e-05	0.0005	CcSEcCtD
Glyburide—Arthralgia—Valproic Acid—epilepsy syndrome	5.87e-05	0.0005	CcSEcCtD
Glyburide—Myalgia—Valproic Acid—epilepsy syndrome	5.87e-05	0.0005	CcSEcCtD
Glyburide—Tremor—Pregabalin—epilepsy syndrome	5.84e-05	0.000497	CcSEcCtD
Glyburide—Feeling abnormal—Lamotrigine—epilepsy syndrome	5.83e-05	0.000497	CcSEcCtD
Glyburide—Rash—Midazolam—epilepsy syndrome	5.83e-05	0.000497	CcSEcCtD
Glyburide—Dermatitis—Midazolam—epilepsy syndrome	5.83e-05	0.000496	CcSEcCtD
Glyburide—Urticaria—Carbamazepine—epilepsy syndrome	5.82e-05	0.000495	CcSEcCtD
Glyburide—Vomiting—Levetiracetam—epilepsy syndrome	5.81e-05	0.000494	CcSEcCtD
Glyburide—Alopecia—Gabapentin—epilepsy syndrome	5.8e-05	0.000494	CcSEcCtD
Glyburide—Headache—Midazolam—epilepsy syndrome	5.79e-05	0.000493	CcSEcCtD
Glyburide—Pruritus—Felbamate—epilepsy syndrome	5.79e-05	0.000493	CcSEcCtD
Glyburide—Abdominal pain—Carbamazepine—epilepsy syndrome	5.79e-05	0.000493	CcSEcCtD
Glyburide—Diarrhoea—Diazepam—epilepsy syndrome	5.79e-05	0.000493	CcSEcCtD
Glyburide—Gastrointestinal pain—Lamotrigine—epilepsy syndrome	5.79e-05	0.000493	CcSEcCtD
Glyburide—Rash—Levetiracetam—epilepsy syndrome	5.76e-05	0.00049	CcSEcCtD
Glyburide—Anaemia—Pregabalin—epilepsy syndrome	5.76e-05	0.00049	CcSEcCtD
Glyburide—Dermatitis—Levetiracetam—epilepsy syndrome	5.75e-05	0.00049	CcSEcCtD
Glyburide—Asthenia—Zonisamide—epilepsy syndrome	5.75e-05	0.00049	CcSEcCtD
Glyburide—Agranulocytosis—Topiramate—epilepsy syndrome	5.74e-05	0.000489	CcSEcCtD
Glyburide—Headache—Levetiracetam—epilepsy syndrome	5.72e-05	0.000487	CcSEcCtD
Glyburide—Malnutrition—Gabapentin—epilepsy syndrome	5.71e-05	0.000486	CcSEcCtD
Glyburide—Erythema—Gabapentin—epilepsy syndrome	5.71e-05	0.000486	CcSEcCtD
Glyburide—Angioedema—Pregabalin—epilepsy syndrome	5.69e-05	0.000485	CcSEcCtD
Glyburide—Hypersensitivity—Clonazepam—epilepsy syndrome	5.69e-05	0.000485	CcSEcCtD
Glyburide—Confusional state—Valproic Acid—epilepsy syndrome	5.67e-05	0.000483	CcSEcCtD
Glyburide—Pruritus—Zonisamide—epilepsy syndrome	5.67e-05	0.000483	CcSEcCtD
Glyburide—Hypersensitivity—Phenytoin—epilepsy syndrome	5.65e-05	0.000481	CcSEcCtD
Glyburide—Oedema—Valproic Acid—epilepsy syndrome	5.62e-05	0.000479	CcSEcCtD
Glyburide—Urticaria—Lamotrigine—epilepsy syndrome	5.62e-05	0.000479	CcSEcCtD
Glyburide—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	5.62e-05	0.000479	CcSEcCtD
Glyburide—Nausea—Propofol—epilepsy syndrome	5.62e-05	0.000478	CcSEcCtD
Glyburide—Vomiting—Fosphenytoin—epilepsy syndrome	5.61e-05	0.000477	CcSEcCtD
Glyburide—Diarrhoea—Felbamate—epilepsy syndrome	5.6e-05	0.000477	CcSEcCtD
Glyburide—Gliclazide—ALB—epilepsy syndrome	5.6e-05	0.017	CrCbGaD
Glyburide—Abdominal pain—Lamotrigine—epilepsy syndrome	5.6e-05	0.000476	CcSEcCtD
Glyburide—ABCB1—nervous system—epilepsy syndrome	5.58e-05	0.00178	CbGeAlD
Glyburide—Leukopenia—Pregabalin—epilepsy syndrome	5.58e-05	0.000475	CcSEcCtD
Glyburide—Rash—Fosphenytoin—epilepsy syndrome	5.56e-05	0.000473	CcSEcCtD
Glyburide—Dermatitis—Fosphenytoin—epilepsy syndrome	5.55e-05	0.000473	CcSEcCtD
Glyburide—Asthenia—Clonazepam—epilepsy syndrome	5.54e-05	0.000472	CcSEcCtD
Glyburide—Headache—Fosphenytoin—epilepsy syndrome	5.52e-05	0.00047	CcSEcCtD
Glyburide—Hepatitis—Topiramate—epilepsy syndrome	5.52e-05	0.00047	CcSEcCtD
Glyburide—Nervous system disorder—Valproic Acid—epilepsy syndrome	5.52e-05	0.00047	CcSEcCtD
Glyburide—Thrombocytopenia—Valproic Acid—epilepsy syndrome	5.51e-05	0.000469	CcSEcCtD
Glyburide—Asthenia—Phenytoin—epilepsy syndrome	5.5e-05	0.000469	CcSEcCtD
Glyburide—Nausea—Midazolam—epilepsy syndrome	5.49e-05	0.000468	CcSEcCtD
Glyburide—Diarrhoea—Zonisamide—epilepsy syndrome	5.48e-05	0.000467	CcSEcCtD
Glyburide—Asthenia—Oxcarbazepine—epilepsy syndrome	5.48e-05	0.000466	CcSEcCtD
Glyburide—Pruritus—Clonazepam—epilepsy syndrome	5.47e-05	0.000465	CcSEcCtD
Glyburide—Vomiting—Vigabatrin—epilepsy syndrome	5.46e-05	0.000465	CcSEcCtD
Glyburide—Hyperhidrosis—Valproic Acid—epilepsy syndrome	5.44e-05	0.000463	CcSEcCtD
Glyburide—Pruritus—Phenytoin—epilepsy syndrome	5.43e-05	0.000462	CcSEcCtD
Glyburide—Nausea—Levetiracetam—epilepsy syndrome	5.43e-05	0.000462	CcSEcCtD
Glyburide—Rash—Vigabatrin—epilepsy syndrome	5.42e-05	0.000461	CcSEcCtD
Glyburide—Dermatitis—Vigabatrin—epilepsy syndrome	5.41e-05	0.000461	CcSEcCtD
Glyburide—Pruritus—Oxcarbazepine—epilepsy syndrome	5.4e-05	0.00046	CcSEcCtD
Glyburide—Convulsion—Pregabalin—epilepsy syndrome	5.4e-05	0.00046	CcSEcCtD
Glyburide—Hypersensitivity—Carbamazepine—epilepsy syndrome	5.4e-05	0.000459	CcSEcCtD
Glyburide—Vision blurred—Gabapentin—epilepsy syndrome	5.38e-05	0.000458	CcSEcCtD
Glyburide—Headache—Vigabatrin—epilepsy syndrome	5.38e-05	0.000458	CcSEcCtD
Glyburide—Vomiting—Diazepam—epilepsy syndrome	5.38e-05	0.000458	CcSEcCtD
Glyburide—ABCB1—central nervous system—epilepsy syndrome	5.37e-05	0.00172	CbGeAlD
Glyburide—Anorexia—Valproic Acid—epilepsy syndrome	5.36e-05	0.000456	CcSEcCtD
Glyburide—Tremor—Gabapentin—epilepsy syndrome	5.35e-05	0.000456	CcSEcCtD
Glyburide—Rash—Diazepam—epilepsy syndrome	5.33e-05	0.000454	CcSEcCtD
Glyburide—Dermatitis—Diazepam—epilepsy syndrome	5.33e-05	0.000454	CcSEcCtD
Glyburide—Visual impairment—Topiramate—epilepsy syndrome	5.32e-05	0.000453	CcSEcCtD
Glyburide—Myalgia—Pregabalin—epilepsy syndrome	5.3e-05	0.000452	CcSEcCtD
Glyburide—Arthralgia—Pregabalin—epilepsy syndrome	5.3e-05	0.000452	CcSEcCtD
Glyburide—Headache—Diazepam—epilepsy syndrome	5.3e-05	0.000451	CcSEcCtD
Glyburide—Diarrhoea—Clonazepam—epilepsy syndrome	5.29e-05	0.00045	CcSEcCtD
Glyburide—Anaemia—Gabapentin—epilepsy syndrome	5.28e-05	0.00045	CcSEcCtD
Glyburide—Hypotension—Valproic Acid—epilepsy syndrome	5.26e-05	0.000447	CcSEcCtD
Glyburide—Asthenia—Carbamazepine—epilepsy syndrome	5.25e-05	0.000447	CcSEcCtD
Glyburide—ABCB1—cerebellum—epilepsy syndrome	5.25e-05	0.00168	CbGeAlD
Glyburide—Diarrhoea—Phenytoin—epilepsy syndrome	5.25e-05	0.000447	CcSEcCtD
Glyburide—Nausea—Fosphenytoin—epilepsy syndrome	5.24e-05	0.000446	CcSEcCtD
Glyburide—Diarrhoea—Oxcarbazepine—epilepsy syndrome	5.22e-05	0.000445	CcSEcCtD
Glyburide—Angioedema—Gabapentin—epilepsy syndrome	5.22e-05	0.000444	CcSEcCtD
Glyburide—Hypersensitivity—Lamotrigine—epilepsy syndrome	5.22e-05	0.000444	CcSEcCtD
Glyburide—Vomiting—Felbamate—epilepsy syndrome	5.21e-05	0.000443	CcSEcCtD
Glyburide—Pruritus—Carbamazepine—epilepsy syndrome	5.18e-05	0.000441	CcSEcCtD
Glyburide—Rash—Felbamate—epilepsy syndrome	5.16e-05	0.00044	CcSEcCtD
Glyburide—Eye disorder—Topiramate—epilepsy syndrome	5.16e-05	0.000439	CcSEcCtD
Glyburide—Dermatitis—Felbamate—epilepsy syndrome	5.16e-05	0.000439	CcSEcCtD
Glyburide—Headache—Felbamate—epilepsy syndrome	5.13e-05	0.000437	CcSEcCtD
Glyburide—Confusional state—Pregabalin—epilepsy syndrome	5.13e-05	0.000437	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	5.12e-05	0.000436	CcSEcCtD
Glyburide—Leukopenia—Gabapentin—epilepsy syndrome	5.11e-05	0.000435	CcSEcCtD
Glyburide—Nausea—Vigabatrin—epilepsy syndrome	5.1e-05	0.000435	CcSEcCtD
Glyburide—Vomiting—Zonisamide—epilepsy syndrome	5.1e-05	0.000434	CcSEcCtD
Glyburide—Oedema—Pregabalin—epilepsy syndrome	5.09e-05	0.000433	CcSEcCtD
Glyburide—Asthenia—Lamotrigine—epilepsy syndrome	5.08e-05	0.000432	CcSEcCtD
Glyburide—Rash—Zonisamide—epilepsy syndrome	5.05e-05	0.00043	CcSEcCtD
Glyburide—Paraesthesia—Valproic Acid—epilepsy syndrome	5.05e-05	0.00043	CcSEcCtD
Glyburide—Dermatitis—Zonisamide—epilepsy syndrome	5.05e-05	0.00043	CcSEcCtD
Glyburide—Nausea—Diazepam—epilepsy syndrome	5.03e-05	0.000428	CcSEcCtD
Glyburide—Headache—Zonisamide—epilepsy syndrome	5.02e-05	0.000427	CcSEcCtD
Glyburide—Dyspnoea—Valproic Acid—epilepsy syndrome	5.01e-05	0.000427	CcSEcCtD
Glyburide—Diarrhoea—Carbamazepine—epilepsy syndrome	5.01e-05	0.000427	CcSEcCtD
Glyburide—Pruritus—Lamotrigine—epilepsy syndrome	5.01e-05	0.000426	CcSEcCtD
Glyburide—Shock—Pregabalin—epilepsy syndrome	5e-05	0.000426	CcSEcCtD
Glyburide—Nervous system disorder—Pregabalin—epilepsy syndrome	4.99e-05	0.000425	CcSEcCtD
Glyburide—Thrombocytopenia—Pregabalin—epilepsy syndrome	4.98e-05	0.000424	CcSEcCtD
Glyburide—Dyspepsia—Valproic Acid—epilepsy syndrome	4.95e-05	0.000422	CcSEcCtD
Glyburide—Convulsion—Gabapentin—epilepsy syndrome	4.95e-05	0.000421	CcSEcCtD
Glyburide—Hyperhidrosis—Pregabalin—epilepsy syndrome	4.92e-05	0.000419	CcSEcCtD
Glyburide—Vomiting—Clonazepam—epilepsy syndrome	4.91e-05	0.000418	CcSEcCtD
Glyburide—Decreased appetite—Valproic Acid—epilepsy syndrome	4.89e-05	0.000416	CcSEcCtD
Glyburide—Alopecia—Topiramate—epilepsy syndrome	4.88e-05	0.000415	CcSEcCtD
Glyburide—Vomiting—Phenytoin—epilepsy syndrome	4.88e-05	0.000415	CcSEcCtD
Glyburide—Rash—Clonazepam—epilepsy syndrome	4.87e-05	0.000415	CcSEcCtD
Glyburide—Dermatitis—Clonazepam—epilepsy syndrome	4.87e-05	0.000414	CcSEcCtD
Glyburide—Arthralgia—Gabapentin—epilepsy syndrome	4.86e-05	0.000414	CcSEcCtD
Glyburide—Myalgia—Gabapentin—epilepsy syndrome	4.86e-05	0.000414	CcSEcCtD
Glyburide—Nausea—Felbamate—epilepsy syndrome	4.86e-05	0.000414	CcSEcCtD
Glyburide—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	4.86e-05	0.000413	CcSEcCtD
Glyburide—Vomiting—Oxcarbazepine—epilepsy syndrome	4.85e-05	0.000413	CcSEcCtD
Glyburide—Anorexia—Pregabalin—epilepsy syndrome	4.85e-05	0.000413	CcSEcCtD
Glyburide—Diarrhoea—Lamotrigine—epilepsy syndrome	4.84e-05	0.000412	CcSEcCtD
Glyburide—Headache—Clonazepam—epilepsy syndrome	4.84e-05	0.000412	CcSEcCtD
Glyburide—Rash—Phenytoin—epilepsy syndrome	4.84e-05	0.000412	CcSEcCtD
Glyburide—Dermatitis—Phenytoin—epilepsy syndrome	4.83e-05	0.000412	CcSEcCtD
Glyburide—Rash—Oxcarbazepine—epilepsy syndrome	4.81e-05	0.00041	CcSEcCtD
Glyburide—Dermatitis—Oxcarbazepine—epilepsy syndrome	4.81e-05	0.000409	CcSEcCtD
Glyburide—Headache—Phenytoin—epilepsy syndrome	4.81e-05	0.000409	CcSEcCtD
Glyburide—Erythema—Topiramate—epilepsy syndrome	4.81e-05	0.000409	CcSEcCtD
Glyburide—Malnutrition—Topiramate—epilepsy syndrome	4.81e-05	0.000409	CcSEcCtD
Glyburide—Headache—Oxcarbazepine—epilepsy syndrome	4.78e-05	0.000407	CcSEcCtD
Glyburide—Nausea—Zonisamide—epilepsy syndrome	4.76e-05	0.000405	CcSEcCtD
Glyburide—Hypotension—Pregabalin—epilepsy syndrome	4.75e-05	0.000405	CcSEcCtD
Glyburide—Confusional state—Gabapentin—epilepsy syndrome	4.7e-05	0.0004	CcSEcCtD
Glyburide—Oedema—Gabapentin—epilepsy syndrome	4.66e-05	0.000397	CcSEcCtD
Glyburide—Vomiting—Carbamazepine—epilepsy syndrome	4.66e-05	0.000396	CcSEcCtD
Glyburide—Feeling abnormal—Valproic Acid—epilepsy syndrome	4.64e-05	0.000395	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	4.63e-05	0.000394	CcSEcCtD
Glyburide—Rash—Carbamazepine—epilepsy syndrome	4.62e-05	0.000393	CcSEcCtD
Glyburide—Dermatitis—Carbamazepine—epilepsy syndrome	4.61e-05	0.000393	CcSEcCtD
Glyburide—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	4.6e-05	0.000392	CcSEcCtD
Glyburide—Nausea—Clonazepam—epilepsy syndrome	4.59e-05	0.000391	CcSEcCtD
Glyburide—Headache—Carbamazepine—epilepsy syndrome	4.59e-05	0.000391	CcSEcCtD
Glyburide—Shock—Gabapentin—epilepsy syndrome	4.59e-05	0.000391	CcSEcCtD
Glyburide—Nervous system disorder—Gabapentin—epilepsy syndrome	4.57e-05	0.000389	CcSEcCtD
Glyburide—Paraesthesia—Pregabalin—epilepsy syndrome	4.57e-05	0.000389	CcSEcCtD
Glyburide—Thrombocytopenia—Gabapentin—epilepsy syndrome	4.57e-05	0.000389	CcSEcCtD
Glyburide—Nausea—Phenytoin—epilepsy syndrome	4.56e-05	0.000388	CcSEcCtD
Glyburide—Dyspnoea—Pregabalin—epilepsy syndrome	4.53e-05	0.000386	CcSEcCtD
Glyburide—Nausea—Oxcarbazepine—epilepsy syndrome	4.53e-05	0.000386	CcSEcCtD
Glyburide—Vision blurred—Topiramate—epilepsy syndrome	4.53e-05	0.000386	CcSEcCtD
Glyburide—Hyperhidrosis—Gabapentin—epilepsy syndrome	4.51e-05	0.000384	CcSEcCtD
Glyburide—Tremor—Topiramate—epilepsy syndrome	4.5e-05	0.000383	CcSEcCtD
Glyburide—Vomiting—Lamotrigine—epilepsy syndrome	4.5e-05	0.000383	CcSEcCtD
Glyburide—Urticaria—Valproic Acid—epilepsy syndrome	4.47e-05	0.00038	CcSEcCtD
Glyburide—Rash—Lamotrigine—epilepsy syndrome	4.46e-05	0.00038	CcSEcCtD
Glyburide—Dermatitis—Lamotrigine—epilepsy syndrome	4.46e-05	0.00038	CcSEcCtD
Glyburide—Abdominal pain—Valproic Acid—epilepsy syndrome	4.45e-05	0.000379	CcSEcCtD
Glyburide—Anorexia—Gabapentin—epilepsy syndrome	4.44e-05	0.000378	CcSEcCtD
Glyburide—Anaemia—Topiramate—epilepsy syndrome	4.44e-05	0.000378	CcSEcCtD
Glyburide—Headache—Lamotrigine—epilepsy syndrome	4.43e-05	0.000378	CcSEcCtD
Glyburide—Decreased appetite—Pregabalin—epilepsy syndrome	4.42e-05	0.000376	CcSEcCtD
Glyburide—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	4.39e-05	0.000374	CcSEcCtD
Glyburide—Hypotension—Gabapentin—epilepsy syndrome	4.36e-05	0.000371	CcSEcCtD
Glyburide—Nausea—Carbamazepine—epilepsy syndrome	4.35e-05	0.00037	CcSEcCtD
Glyburide—Leukopenia—Topiramate—epilepsy syndrome	4.3e-05	0.000366	CcSEcCtD
Glyburide—ABCB1—brain—epilepsy syndrome	4.27e-05	0.00136	CbGeAlD
Glyburide—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	4.25e-05	0.000362	CcSEcCtD
Glyburide—Nausea—Lamotrigine—epilepsy syndrome	4.2e-05	0.000358	CcSEcCtD
Glyburide—Feeling abnormal—Pregabalin—epilepsy syndrome	4.19e-05	0.000357	CcSEcCtD
Glyburide—Paraesthesia—Gabapentin—epilepsy syndrome	4.19e-05	0.000356	CcSEcCtD
Glyburide—Convulsion—Topiramate—epilepsy syndrome	4.16e-05	0.000355	CcSEcCtD
Glyburide—Gastrointestinal pain—Pregabalin—epilepsy syndrome	4.16e-05	0.000354	CcSEcCtD
Glyburide—Dyspnoea—Gabapentin—epilepsy syndrome	4.16e-05	0.000354	CcSEcCtD
Glyburide—Chlorpropamide—ABCB1—epilepsy syndrome	4.16e-05	0.0126	CrCbGaD
Glyburide—Hypersensitivity—Valproic Acid—epilepsy syndrome	4.14e-05	0.000353	CcSEcCtD
Glyburide—Dyspepsia—Gabapentin—epilepsy syndrome	4.1e-05	0.000349	CcSEcCtD
Glyburide—Myalgia—Topiramate—epilepsy syndrome	4.09e-05	0.000348	CcSEcCtD
Glyburide—Arthralgia—Topiramate—epilepsy syndrome	4.09e-05	0.000348	CcSEcCtD
Glyburide—Decreased appetite—Gabapentin—epilepsy syndrome	4.05e-05	0.000345	CcSEcCtD
Glyburide—Urticaria—Pregabalin—epilepsy syndrome	4.04e-05	0.000344	CcSEcCtD
Glyburide—Asthenia—Valproic Acid—epilepsy syndrome	4.04e-05	0.000344	CcSEcCtD
Glyburide—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	4.03e-05	0.000343	CcSEcCtD
Glyburide—Abdominal pain—Pregabalin—epilepsy syndrome	4.02e-05	0.000342	CcSEcCtD
Glyburide—Pruritus—Valproic Acid—epilepsy syndrome	3.98e-05	0.000339	CcSEcCtD
Glyburide—Confusional state—Topiramate—epilepsy syndrome	3.96e-05	0.000337	CcSEcCtD
Glyburide—Oedema—Topiramate—epilepsy syndrome	3.92e-05	0.000334	CcSEcCtD
Glyburide—Shock—Topiramate—epilepsy syndrome	3.86e-05	0.000329	CcSEcCtD
Glyburide—Diarrhoea—Valproic Acid—epilepsy syndrome	3.85e-05	0.000328	CcSEcCtD
Glyburide—Nervous system disorder—Topiramate—epilepsy syndrome	3.85e-05	0.000328	CcSEcCtD
Glyburide—Feeling abnormal—Gabapentin—epilepsy syndrome	3.84e-05	0.000327	CcSEcCtD
Glyburide—Thrombocytopenia—Topiramate—epilepsy syndrome	3.84e-05	0.000327	CcSEcCtD
Glyburide—Gastrointestinal pain—Gabapentin—epilepsy syndrome	3.81e-05	0.000325	CcSEcCtD
Glyburide—Hyperhidrosis—Topiramate—epilepsy syndrome	3.79e-05	0.000323	CcSEcCtD
Glyburide—Hypersensitivity—Pregabalin—epilepsy syndrome	3.75e-05	0.000319	CcSEcCtD
Glyburide—Anorexia—Topiramate—epilepsy syndrome	3.74e-05	0.000318	CcSEcCtD
Glyburide—Urticaria—Gabapentin—epilepsy syndrome	3.7e-05	0.000315	CcSEcCtD
Glyburide—Abdominal pain—Gabapentin—epilepsy syndrome	3.69e-05	0.000314	CcSEcCtD
Glyburide—Hypotension—Topiramate—epilepsy syndrome	3.67e-05	0.000312	CcSEcCtD
Glyburide—Asthenia—Pregabalin—epilepsy syndrome	3.65e-05	0.000311	CcSEcCtD
Glyburide—Pruritus—Pregabalin—epilepsy syndrome	3.6e-05	0.000306	CcSEcCtD
Glyburide—Vomiting—Valproic Acid—epilepsy syndrome	3.58e-05	0.000304	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	3.57e-05	0.000304	CcSEcCtD
Glyburide—Rash—Valproic Acid—epilepsy syndrome	3.55e-05	0.000302	CcSEcCtD
Glyburide—Dermatitis—Valproic Acid—epilepsy syndrome	3.54e-05	0.000302	CcSEcCtD
Glyburide—Headache—Valproic Acid—epilepsy syndrome	3.52e-05	0.0003	CcSEcCtD
Glyburide—Paraesthesia—Topiramate—epilepsy syndrome	3.52e-05	0.0003	CcSEcCtD
Glyburide—Dyspnoea—Topiramate—epilepsy syndrome	3.5e-05	0.000298	CcSEcCtD
Glyburide—Diarrhoea—Pregabalin—epilepsy syndrome	3.48e-05	0.000296	CcSEcCtD
Glyburide—Dyspepsia—Topiramate—epilepsy syndrome	3.45e-05	0.000294	CcSEcCtD
Glyburide—Hypersensitivity—Gabapentin—epilepsy syndrome	3.44e-05	0.000292	CcSEcCtD
Glyburide—Decreased appetite—Topiramate—epilepsy syndrome	3.41e-05	0.00029	CcSEcCtD
Glyburide—Gastrointestinal disorder—Topiramate—epilepsy syndrome	3.39e-05	0.000288	CcSEcCtD
Glyburide—Asthenia—Gabapentin—epilepsy syndrome	3.35e-05	0.000285	CcSEcCtD
Glyburide—Nausea—Valproic Acid—epilepsy syndrome	3.34e-05	0.000284	CcSEcCtD
Glyburide—Pruritus—Gabapentin—epilepsy syndrome	3.3e-05	0.000281	CcSEcCtD
Glyburide—Vomiting—Pregabalin—epilepsy syndrome	3.23e-05	0.000275	CcSEcCtD
Glyburide—Feeling abnormal—Topiramate—epilepsy syndrome	3.23e-05	0.000275	CcSEcCtD
Glyburide—Gastrointestinal pain—Topiramate—epilepsy syndrome	3.21e-05	0.000273	CcSEcCtD
Glyburide—Rash—Pregabalin—epilepsy syndrome	3.21e-05	0.000273	CcSEcCtD
Glyburide—Dermatitis—Pregabalin—epilepsy syndrome	3.2e-05	0.000273	CcSEcCtD
Glyburide—Diarrhoea—Gabapentin—epilepsy syndrome	3.19e-05	0.000272	CcSEcCtD
Glyburide—Headache—Pregabalin—epilepsy syndrome	3.19e-05	0.000271	CcSEcCtD
Glyburide—Urticaria—Topiramate—epilepsy syndrome	3.12e-05	0.000265	CcSEcCtD
Glyburide—Abdominal pain—Topiramate—epilepsy syndrome	3.1e-05	0.000264	CcSEcCtD
Glyburide—Nausea—Pregabalin—epilepsy syndrome	3.02e-05	0.000257	CcSEcCtD
Glyburide—Vomiting—Gabapentin—epilepsy syndrome	2.96e-05	0.000252	CcSEcCtD
Glyburide—Rash—Gabapentin—epilepsy syndrome	2.94e-05	0.00025	CcSEcCtD
Glyburide—Dermatitis—Gabapentin—epilepsy syndrome	2.94e-05	0.00025	CcSEcCtD
Glyburide—Headache—Gabapentin—epilepsy syndrome	2.92e-05	0.000249	CcSEcCtD
Glyburide—Hypersensitivity—Topiramate—epilepsy syndrome	2.89e-05	0.000246	CcSEcCtD
Glyburide—Asthenia—Topiramate—epilepsy syndrome	2.81e-05	0.00024	CcSEcCtD
Glyburide—Pruritus—Topiramate—epilepsy syndrome	2.78e-05	0.000236	CcSEcCtD
Glyburide—Nausea—Gabapentin—epilepsy syndrome	2.77e-05	0.000236	CcSEcCtD
Glyburide—Diarrhoea—Topiramate—epilepsy syndrome	2.68e-05	0.000229	CcSEcCtD
Glyburide—Vomiting—Topiramate—epilepsy syndrome	2.49e-05	0.000212	CcSEcCtD
Glyburide—Rash—Topiramate—epilepsy syndrome	2.47e-05	0.000211	CcSEcCtD
Glyburide—Dermatitis—Topiramate—epilepsy syndrome	2.47e-05	0.00021	CcSEcCtD
Glyburide—Headache—Topiramate—epilepsy syndrome	2.46e-05	0.000209	CcSEcCtD
Glyburide—Nausea—Topiramate—epilepsy syndrome	2.33e-05	0.000198	CcSEcCtD
Glyburide—CYP3A4—Metabolism—QDPR—epilepsy syndrome	2.05e-06	1.97e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—CA4—epilepsy syndrome	2.05e-06	1.97e-05	CbGpPWpGaD
Glyburide—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	2.04e-06	1.96e-05	CbGpPWpGaD
Glyburide—ABCG2—Transmembrane transport of small molecules—ALB—epilepsy syndrome	2.04e-06	1.96e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—ADRA2A—epilepsy syndrome	2.04e-06	1.95e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—BCHE—epilepsy syndrome	2.03e-06	1.95e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—CACNA1D—epilepsy syndrome	2.03e-06	1.94e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—HES1—epilepsy syndrome	2.02e-06	1.94e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—GLUL—epilepsy syndrome	2.01e-06	1.93e-05	CbGpPWpGaD
Glyburide—ALB—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	2.01e-06	1.93e-05	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—HMOX1—epilepsy syndrome	2.01e-06	1.93e-05	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—POMC—epilepsy syndrome	2.01e-06	1.93e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—ALDH7A1—epilepsy syndrome	2e-06	1.92e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—CACNA1A—epilepsy syndrome	2e-06	1.92e-05	CbGpPWpGaD
Glyburide—ALB—Platelet activation, signaling and aggregation—SRC—epilepsy syndrome	2e-06	1.92e-05	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—CAT—epilepsy syndrome	1.98e-06	1.9e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—CACNA1D—epilepsy syndrome	1.98e-06	1.9e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—FYN—epilepsy syndrome	1.97e-06	1.89e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	1.97e-06	1.89e-05	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—epilepsy syndrome	1.97e-06	1.89e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—H2AFX—epilepsy syndrome	1.96e-06	1.88e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—ST3GAL3—epilepsy syndrome	1.96e-06	1.88e-05	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—POMC—epilepsy syndrome	1.94e-06	1.87e-05	CbGpPWpGaD
Glyburide—ALB—Platelet activation, signaling and aggregation—VEGFA—epilepsy syndrome	1.94e-06	1.87e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—SLC2A1—epilepsy syndrome	1.93e-06	1.86e-05	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—ABCB1—epilepsy syndrome	1.93e-06	1.85e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—COX3—epilepsy syndrome	1.93e-06	1.85e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—ADSL—epilepsy syndrome	1.92e-06	1.84e-05	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—epilepsy syndrome	1.91e-06	1.84e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—PLCB1—epilepsy syndrome	1.91e-06	1.84e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—TH—epilepsy syndrome	1.91e-06	1.83e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—TXNRD1—epilepsy syndrome	1.89e-06	1.82e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—YWHAZ—epilepsy syndrome	1.89e-06	1.82e-05	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—AGT—epilepsy syndrome	1.88e-06	1.81e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—PLAU—epilepsy syndrome	1.88e-06	1.81e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—GLUL—epilepsy syndrome	1.88e-06	1.81e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—KCNJ11—epilepsy syndrome	1.85e-06	1.78e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—CHRM3—epilepsy syndrome	1.85e-06	1.78e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—TXNRD1—epilepsy syndrome	1.85e-06	1.77e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—CACNA1D—epilepsy syndrome	1.85e-06	1.77e-05	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—APOE—epilepsy syndrome	1.85e-06	1.77e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—AQP1—epilepsy syndrome	1.84e-06	1.77e-05	CbGpPWpGaD
Glyburide—ABCB1—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	1.84e-06	1.76e-05	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—ALB—epilepsy syndrome	1.83e-06	1.76e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	1.83e-06	1.75e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	1.83e-06	1.75e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	1.83e-06	1.75e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PFKL—epilepsy syndrome	1.83e-06	1.75e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	1.83e-06	1.75e-05	CbGpPWpGaD
Glyburide—ABCB1—Transmembrane transport of small molecules—AVP—epilepsy syndrome	1.82e-06	1.75e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—CCR5—epilepsy syndrome	1.82e-06	1.75e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—HMOX1—epilepsy syndrome	1.81e-06	1.74e-05	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—AGT—epilepsy syndrome	1.81e-06	1.73e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—AQP1—epilepsy syndrome	1.79e-06	1.72e-05	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—GPX1—epilepsy syndrome	1.79e-06	1.72e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—CAT—epilepsy syndrome	1.78e-06	1.71e-05	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—ALB—epilepsy syndrome	1.77e-06	1.7e-05	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—APOE—epilepsy syndrome	1.77e-06	1.7e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	1.77e-06	1.7e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—PRKCB—epilepsy syndrome	1.75e-06	1.68e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—ABCB1—epilepsy syndrome	1.74e-06	1.67e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—NOS2—epilepsy syndrome	1.73e-06	1.66e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—TXNRD1—epilepsy syndrome	1.73e-06	1.66e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	1.73e-06	1.66e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—TSC2—epilepsy syndrome	1.69e-06	1.62e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	1.69e-06	1.62e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—AQP1—epilepsy syndrome	1.68e-06	1.61e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—NEU1—epilepsy syndrome	1.67e-06	1.6e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—ATIC—epilepsy syndrome	1.67e-06	1.6e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—UPB1—epilepsy syndrome	1.67e-06	1.6e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—CHRM3—epilepsy syndrome	1.66e-06	1.6e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—KCNJ11—epilepsy syndrome	1.66e-06	1.6e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—APOE—epilepsy syndrome	1.66e-06	1.59e-05	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	1.64e-06	1.57e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—KCNJ11—epilepsy syndrome	1.62e-06	1.56e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—CHRM3—epilepsy syndrome	1.62e-06	1.56e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—GPX1—epilepsy syndrome	1.61e-06	1.55e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	1.61e-06	1.55e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	1.61e-06	1.54e-05	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—PTGS2—epilepsy syndrome	1.6e-06	1.54e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—HMOX1—epilepsy syndrome	1.59e-06	1.53e-05	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—POMC—epilepsy syndrome	1.59e-06	1.52e-05	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—AGT—epilepsy syndrome	1.57e-06	1.51e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—CAT—epilepsy syndrome	1.57e-06	1.51e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—IL6ST—epilepsy syndrome	1.55e-06	1.49e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—GBE1—epilepsy syndrome	1.55e-06	1.49e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	1.55e-06	1.49e-05	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—PTGS2—epilepsy syndrome	1.55e-06	1.49e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	1.55e-06	1.49e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—NOS2—epilepsy syndrome	1.54e-06	1.48e-05	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—APOE—epilepsy syndrome	1.54e-06	1.48e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—ABCB1—epilepsy syndrome	1.53e-06	1.47e-05	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—POMC—epilepsy syndrome	1.52e-06	1.46e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	1.52e-06	1.46e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—KCNJ11—epilepsy syndrome	1.52e-06	1.46e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—CHRM3—epilepsy syndrome	1.52e-06	1.46e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—ABCG2—epilepsy syndrome	1.51e-06	1.45e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—CYP2C19—epilepsy syndrome	1.47e-06	1.41e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—CYP11A1—epilepsy syndrome	1.46e-06	1.4e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	1.46e-06	1.4e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.45e-06	1.39e-05	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—ALB—epilepsy syndrome	1.45e-06	1.39e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—GPX1—epilepsy syndrome	1.42e-06	1.36e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	1.42e-06	1.36e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—AGT—epilepsy syndrome	1.41e-06	1.36e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	1.41e-06	1.36e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—APOE—epilepsy syndrome	1.39e-06	1.33e-05	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—ALB—epilepsy syndrome	1.39e-06	1.33e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	1.38e-06	1.33e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—NT5E—epilepsy syndrome	1.38e-06	1.33e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—ALAD—epilepsy syndrome	1.38e-06	1.33e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—ABCG2—epilepsy syndrome	1.36e-06	1.3e-05	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—POMC—epilepsy syndrome	1.32e-06	1.27e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—ABCG2—epilepsy syndrome	1.32e-06	1.27e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—CYP2D6—epilepsy syndrome	1.32e-06	1.27e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	1.32e-06	1.27e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	1.32e-06	1.27e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—CYP11A1—epilepsy syndrome	1.31e-06	1.26e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.3e-06	1.25e-05	CbGpPWpGaD
Glyburide—CPT1A—Metabolism—AKT1—epilepsy syndrome	1.3e-06	1.25e-05	CbGpPWpGaD
Glyburide—ABCA1—Metabolism—AKT1—epilepsy syndrome	1.3e-06	1.25e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	1.29e-06	1.24e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—CYP2C19—epilepsy syndrome	1.29e-06	1.24e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—CYP11A1—epilepsy syndrome	1.28e-06	1.23e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—ADSL—epilepsy syndrome	1.27e-06	1.21e-05	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—PTGS2—epilepsy syndrome	1.26e-06	1.21e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—FGF2—epilepsy syndrome	1.26e-06	1.21e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—ADRA2A—epilepsy syndrome	1.26e-06	1.21e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—BCHE—epilepsy syndrome	1.25e-06	1.2e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—AGT—epilepsy syndrome	1.25e-06	1.2e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—GLUL—epilepsy syndrome	1.24e-06	1.19e-05	CbGpPWpGaD
Glyburide—ALB—Platelet activation, signaling and aggregation—AKT1—epilepsy syndrome	1.24e-06	1.19e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—ABCG2—epilepsy syndrome	1.24e-06	1.19e-05	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	1.22e-06	1.17e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—APOE—epilepsy syndrome	1.22e-06	1.17e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	1.22e-06	1.17e-05	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—PTGS2—epilepsy syndrome	1.21e-06	1.16e-05	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—ALB—epilepsy syndrome	1.21e-06	1.16e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—CYP2C19—epilepsy syndrome	1.2e-06	1.16e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—CYP11A1—epilepsy syndrome	1.2e-06	1.15e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—SLC2A1—epilepsy syndrome	1.19e-06	1.15e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—POMC—epilepsy syndrome	1.19e-06	1.14e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.19e-06	1.14e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.19e-06	1.14e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—CYP2D6—epilepsy syndrome	1.18e-06	1.14e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—PLCB1—epilepsy syndrome	1.18e-06	1.13e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—TH—epilepsy syndrome	1.18e-06	1.13e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.16e-06	1.11e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—CYP2D6—epilepsy syndrome	1.16e-06	1.11e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—MTOR—epilepsy syndrome	1.14e-06	1.1e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	1.14e-06	1.09e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—PTGS2—epilepsy syndrome	1.13e-06	1.09e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—ADRA2A—epilepsy syndrome	1.13e-06	1.08e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—BCHE—epilepsy syndrome	1.12e-06	1.08e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—AQP1—epilepsy syndrome	1.11e-06	1.06e-05	CbGpPWpGaD
Glyburide—ABCB1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	1.1e-06	1.06e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—ADRA2A—epilepsy syndrome	1.1e-06	1.06e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—BCHE—epilepsy syndrome	1.1e-06	1.05e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—ALB—epilepsy syndrome	1.09e-06	1.04e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.08e-06	1.04e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—CYP2D6—epilepsy syndrome	1.08e-06	1.04e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—SLC2A1—epilepsy syndrome	1.07e-06	1.03e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—PLCB1—epilepsy syndrome	1.06e-06	1.02e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—TH—epilepsy syndrome	1.06e-06	1.01e-05	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—PTGS2—epilepsy syndrome	1.06e-06	1.01e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—POMC—epilepsy syndrome	1.05e-06	1.01e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—SLC2A1—epilepsy syndrome	1.05e-06	1e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.04e-06	9.98e-06	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—PLCB1—epilepsy syndrome	1.03e-06	9.93e-06	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—TH—epilepsy syndrome	1.03e-06	9.89e-06	CbGpPWpGaD
Glyburide—ALB—Hemostasis—SRC—epilepsy syndrome	1.03e-06	9.88e-06	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—ADRA2A—epilepsy syndrome	1.03e-06	9.87e-06	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—BCHE—epilepsy syndrome	1.02e-06	9.83e-06	CbGpPWpGaD
Glyburide—ALB—Hemostasis—VEGFA—epilepsy syndrome	1e-06	9.62e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	1e-06	9.6e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	1e-06	9.6e-06	CbGpPWpGaD
Glyburide—ALB—Metabolism—HMOX1—epilepsy syndrome	9.82e-07	9.43e-06	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—SLC2A1—epilepsy syndrome	9.77e-07	9.38e-06	CbGpPWpGaD
Glyburide—ALB—Metabolism—CAT—epilepsy syndrome	9.69e-07	9.3e-06	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—PLCB1—epilepsy syndrome	9.66e-07	9.28e-06	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—TH—epilepsy syndrome	9.63e-07	9.24e-06	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—ALB—epilepsy syndrome	9.55e-07	9.17e-06	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—PTGS2—epilepsy syndrome	9.5e-07	9.12e-06	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	9.48e-07	9.1e-06	CbGpPWpGaD
Glyburide—ALB—Metabolism—ABCB1—epilepsy syndrome	9.42e-07	9.05e-06	CbGpPWpGaD
Glyburide—ABCC1—Disease—SRC—epilepsy syndrome	9.17e-07	8.81e-06	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—HMOX1—epilepsy syndrome	8.81e-07	8.46e-06	CbGpPWpGaD
Glyburide—ALB—Metabolism—GPX1—epilepsy syndrome	8.76e-07	8.41e-06	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—CAT—epilepsy syndrome	8.7e-07	8.35e-06	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—HMOX1—epilepsy syndrome	8.6e-07	8.26e-06	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—CAT—epilepsy syndrome	8.49e-07	8.15e-06	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—ABCB1—epilepsy syndrome	8.46e-07	8.12e-06	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—PTGS2—epilepsy syndrome	8.36e-07	8.02e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	8.15e-07	7.83e-06	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—AKT1—epilepsy syndrome	8.04e-07	7.72e-06	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—HMOX1—epilepsy syndrome	8.04e-07	7.71e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	7.94e-07	7.63e-06	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—CAT—epilepsy syndrome	7.93e-07	7.61e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	7.9e-07	7.58e-06	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—GPX1—epilepsy syndrome	7.87e-07	7.55e-06	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—AKT1—epilepsy syndrome	7.8e-07	7.48e-06	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—ABCB1—epilepsy syndrome	7.71e-07	7.41e-06	CbGpPWpGaD
Glyburide—ALB—Metabolism—AGT—epilepsy syndrome	7.68e-07	7.37e-06	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—GPX1—epilepsy syndrome	7.68e-07	7.37e-06	CbGpPWpGaD
Glyburide—ALB—Metabolism—APOE—epilepsy syndrome	7.53e-07	7.23e-06	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—GPX1—epilepsy syndrome	7.17e-07	6.88e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	7.13e-07	6.84e-06	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—AGT—epilepsy syndrome	6.9e-07	6.62e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	6.78e-07	6.51e-06	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—APOE—epilepsy syndrome	6.76e-07	6.49e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—BCHE—epilepsy syndrome	6.75e-07	6.48e-06	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—AGT—epilepsy syndrome	6.73e-07	6.46e-06	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—APOE—epilepsy syndrome	6.6e-07	6.33e-06	CbGpPWpGaD
Glyburide—ALB—Metabolism—POMC—epilepsy syndrome	6.47e-07	6.21e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	6.44e-07	6.19e-06	CbGpPWpGaD
Glyburide—ALB—Hemostasis—AKT1—epilepsy syndrome	6.39e-07	6.14e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	6.37e-07	6.12e-06	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—AKT1—epilepsy syndrome	6.36e-07	6.1e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—TH—epilepsy syndrome	6.35e-07	6.1e-06	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—AGT—epilepsy syndrome	6.29e-07	6.04e-06	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—APOE—epilepsy syndrome	6.16e-07	5.91e-06	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—AKT1—epilepsy syndrome	6.09e-07	5.85e-06	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—POMC—epilepsy syndrome	5.81e-07	5.57e-06	CbGpPWpGaD
Glyburide—ABCC1—Disease—AKT1—epilepsy syndrome	5.7e-07	5.47e-06	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—POMC—epilepsy syndrome	5.67e-07	5.44e-06	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—AKT1—epilepsy syndrome	5.31e-07	5.09e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	5.3e-07	5.09e-06	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—POMC—epilepsy syndrome	5.29e-07	5.08e-06	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—ALB—epilepsy syndrome	5.29e-07	5.08e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—CAT—epilepsy syndrome	5.23e-07	5.02e-06	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—ALB—epilepsy syndrome	5.17e-07	4.96e-06	CbGpPWpGaD
Glyburide—ALB—Metabolism—PTGS2—epilepsy syndrome	5.16e-07	4.95e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	5.09e-07	4.88e-06	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—ALB—epilepsy syndrome	4.83e-07	4.63e-06	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—AKT1—epilepsy syndrome	4.77e-07	4.58e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—GPX1—epilepsy syndrome	4.73e-07	4.54e-06	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—PTGS2—epilepsy syndrome	4.63e-07	4.44e-06	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—PTGS2—epilepsy syndrome	4.52e-07	4.34e-06	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—PTGS2—epilepsy syndrome	4.22e-07	4.05e-06	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—AKT1—epilepsy syndrome	4.2e-07	4.03e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—AGT—epilepsy syndrome	4.15e-07	3.98e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—APOE—epilepsy syndrome	4.06e-07	3.9e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—POMC—epilepsy syndrome	3.49e-07	3.35e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—ALB—epilepsy syndrome	3.18e-07	3.06e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	2.78e-07	2.67e-06	CbGpPWpGaD
Glyburide—ALB—Metabolism—AKT1—epilepsy syndrome	2.59e-07	2.49e-06	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—AKT1—epilepsy syndrome	2.33e-07	2.23e-06	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—AKT1—epilepsy syndrome	2.27e-07	2.18e-06	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—AKT1—epilepsy syndrome	2.12e-07	2.04e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—AKT1—epilepsy syndrome	1.4e-07	1.34e-06	CbGpPWpGaD
